Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel N Maslow

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Tropical Medicine and Infectious Disease|July 25, 2019
Zika Vaccine Development-Current Progress and Challenges for the FutureJoel N Maslow
Human Vaccines & Immunotherapeutics|October 24, 2019
Challenges and solutions in the development of vaccines against emerging and neglected infectious diseasesJoel N Maslow
Vaccine|February 21, 2017
Vaccine development for emerging virulent infectious diseasesJoel N Maslow
Human Vaccines & Immunotherapeutics|August 29, 2017
Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virusJoel N Maslow
Vaccines|October 4, 2018
Assay Challenges for Emerging Infectious Diseases: The Zika ExperienceChristine C Roberts, Joel N Maslow
Methods in Molecular Biology (Clifton, N.J.)|May 6, 2020
Zika Virus: A Brief History and Review of Its Pathogenesis RediscoveredJoel N Maslow, Christine C Roberts
FEMS Microbiology Letters|May 19, 2005
Induction of murine macrophage TNF-alpha synthesis by Mycobacterium avium is modulated through complement-dependent interaction via complement receptors 3 and 4 in relation to M. avium glycopeptidolipidVida R Irani, Joel N Maslow
Tuberculosis (Edinburgh, Scotland)|March 15, 2011
Tuberculosis at the human-animal interface: an emerging disease of elephantsSusan K Mikota, Joel N Maslow
Emerging Infectious Diseases|June 21, 2005
Fluoroquinolone-resistant Escherichia coli carriage in long-term care facilityJoel N Maslow, Betsy Lee, Ebbing Lautenbach
Infection Control and Hospital Epidemiology|March 19, 2009
Risk factors for fecal colonization with multiple distinct strains of Escherichia coli among long-term care facility residentsEbbing Lautenbach, Pam Tolomeo, Nicole Black, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Tropical Medicine and Infectious Disease|July 25, 2019
Zika Vaccine Development-Current Progress and Challenges for the FutureJoel N Maslow
Human Vaccines & Immunotherapeutics|October 24, 2019
Challenges and solutions in the development of vaccines against emerging and neglected infectious diseasesJoel N Maslow
Vaccine|February 21, 2017
Vaccine development for emerging virulent infectious diseasesJoel N Maslow
Human Vaccines & Immunotherapeutics|August 29, 2017
Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virusJoel N Maslow
Vaccines|October 4, 2018
Assay Challenges for Emerging Infectious Diseases: The Zika ExperienceChristine C Roberts, Joel N Maslow
Methods in Molecular Biology (Clifton, N.J.)|May 6, 2020
Zika Virus: A Brief History and Review of Its Pathogenesis RediscoveredJoel N Maslow, Christine C Roberts
FEMS Microbiology Letters|May 19, 2005
Induction of murine macrophage TNF-alpha synthesis by Mycobacterium avium is modulated through complement-dependent interaction via complement receptors 3 and 4 in relation to M. avium glycopeptidolipidVida R Irani, Joel N Maslow
Tuberculosis (Edinburgh, Scotland)|March 15, 2011
Tuberculosis at the human-animal interface: an emerging disease of elephantsSusan K Mikota, Joel N Maslow
Emerging Infectious Diseases|June 21, 2005
Fluoroquinolone-resistant Escherichia coli carriage in long-term care facilityJoel N Maslow, Betsy Lee, Ebbing Lautenbach
Infection Control and Hospital Epidemiology|March 19, 2009
Risk factors for fecal colonization with multiple distinct strains of Escherichia coli among long-term care facility residentsEbbing Lautenbach, Pam Tolomeo, Nicole Black, et al.
Pageof 5